events

MedTech Monitor 2024

When:
Hosted By:
Fox Rothschild and DuVal & Associates, P.A.
People:
Location:
Fox Rothschild

City Center

33 S. Sixth Street, Suite 3600

Minneapolis, MN 55402

Share on:

Join fellow MedTech industry leaders, including CEOs, venture capitalists, in-house legal counsel and regulatory professionals, for a day-long conference on a variety of timely topics.

This can’t-miss event, co-hosted by Fox Rothschild and DuVal & Associates, P.A., will provide updates and practical takeaways.

The event opens with breakfast. A networking cocktail hour will follow the presentations. 

Agenda

8 am    Breakfast and registration

8:30 am    Welcome Remarks

8:45 - 9:45 am    Evidence Strategies Through the Lenses of FDA Appeals and Payer Needs 

  • Mark DuVal, CEO, DuVal & Associates
  • Chris Lyle, VP Evidence Strategy, DuVal & Associates

9:45 - 10:30 am    Building Relationships with VCs:  Advice for Emerging Startups

  • David Adair, M.D., Co-Founder & Managing Director, Solas BioVentures
  • Jeff Peters, Venture Partner, OrbiMed Advisors, LLC
  • Tom Moran, MedTech Partner, Fox Rothschild
  • Interviewer: Kathryn Dehn, MedTech Partner, Fox Rothschild

10:30 - 10:45 am    Morning Break

10:45-11:45 am    Cybersecurity Updates

  • Mark McCreary, Chief Artificial Intelligence & Information Security Officer, Fox Rothschild

11:45 am – Noon    Lunch Break

12:00 pm – 12:45    Demystifying the TAP Advisor Role: Insights into CDRH's Total Product Life Cycle Advisory Program

  • Kai Kadoich, TAP Advisor, FDA Center for Devices and Radiological Health
  • Interviewer: Mark DuVal, CEO, DuVal & Associates

12:45 - 1:15 pm    Key Legal Updates: Corporate Transparency Act 

  • JT Schuweiler, Corporate Partner, Fox Rothschild

1:15 - 1:45 pm    Key Legal Updates: FTC/Noncompete Agreements

  • Jenny Fuller, Employment Partner, Fox Rothschild

1:45 - 2 pm    Afternoon Break

2 – 3 pm    Chevron/Loper Bright and Beyond

  • Bryan Feldhaus, President, DuVal & Associates
  • Morgan McCall Reece, Litigation Counsel, Fox Rothschild

3 - 4 pm    Current Issues and Trends in Achieving Optimal Reimbursement

  • Jolayne Devers, Partner, JD Lymon Group
  • Carla Monacelli, Partner, JD Lymon Group
  • Mark Domyahn, Partner, JD Lymon Group
  • Interviewer: Chris Lyle, VP Evidence Strategy, DuVal & Associates

4 pm    Closing Remarks/Cocktail Reception